CClinicalTrials.gg
CompletedNCT04296448Updated Aug 26, 2021Results posted

Evaluation of Cellphone Based Otoscopy in Pediatric Patients

An interventional study of Cellscope in Ear Infection, Pediatric Disease and Acute Otitis Media, sponsored by Johns Hopkins University. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2021-08-26.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Sep 2019, registered Mar 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
197
Allocation
Randomized
Sex
All
01

Study summary

The Cellscope is an iPhone-based otoscope that uses the iPhone camera and light source to capture HIPAA compliant images and video recordings of the external and middle ear structure. This technology allows multiple providers, at different levels of training, the ability to simultaneously exam a child's external and middle ear structures. The investigators hypothesize this device will result in improved concordance in trainee/supervisor exam findings, increase trainee confidence in exam findings, decreased antibiotic prescriptions, and fewer repeat exams by multiple providers. Thus, this study has the potential to improve physician training and examination confidence, decrease the unnecessary use of antibiotics, and improve the patient/caregiver experience in healthcare interactions.

Read the detailed description

Abstract

Concerns about middle and external ear infections and discomfort are frequent chief complaints that bring children to pediatric providers. On top of this, there are numerous non-ear complaints (e.g. head trauma) that warrant a complete evaluation of the middle and external ear structures. At present, the middle and external ear is examined with standard direct otoscopy, commonly using a handheld otoscope. Otoscopy is defined as the visualization of the external and middle ear structures, including the tympanic membrane, ossicles, middle ear fluid, ear canal, etc. The skill of otoscopy is taught early in the medical trainees' career, most often in the first or second year of medical school. This skill is further honed during the pediatric medical student clerkship and pediatric residency, however there is not an efficient and patient-centered mechanism for direct visualization and teaching of trainees. Because of this, it is nearly impossible for trainees to receive feedback on trainees' visualization and interpretation skills. Based on the investigators' experience, trainee exams are often not repeated by clinical supervisors as the trainees progress in training. When supervisors do repeat ear exams (i.e., trainee is uncertain of findings), it is challenging to determine if the trainee fully appreciates exam findings. Ear exam findings directly inform the clinical decision-making (e.g., prescribing antibiotics for acute otitis media (AOM)) and uncertainty often results in unnecessary prescribing.

Objectives

Aim 1: To establish whether a smartphone otoscope improves diagnostic accuracy of tympanic membrane (TM) pathology for trainees, compared to supervisor.

Aim 2: To determine whether smartphone otoscope improves diagnostic confidence of trainees, thereby reducing frequency of antibiotic prescriptions for AOM.

Aim 3: To determine whether there is a change in repeat exam rates by supervisors, comparing with/without Cellscope.

Aim 4: To determine whether trainees convert to traditional otoscope use during the weeks that Cellscope is available.

02

Conditions studied

  • Ear Infection
  • Pediatric Disease
  • Acute Otitis Media

Keywords

  • cellscope
  • mobile device
  • pediatric trainees
  • acute otitis media
  • ear infection
03

In context

Otitis

246 studies on the registry are indexed under Otitis; 21 are open to participants now.

This study's enrollment of 197 is above the median of 126 across 173 interventional studies indexed under Otitis.

Browse Otitis studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All trainees and supervisors
  • All patients where otoscopy would traditionally be indicated, at the discretion of the clinical team

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
197 participants (actual)

Study arms

  • No intervention
    Traditional Otoscope

    Pediatric trainees use a traditional otoscope to evaluate pediatric patient ears. Trainees' supervisors will also evaluate patients with the traditional otoscope. The study evaluates concordance of the exams.

  • Experimental
    Cellscope

    Pediatric trainees use a cellphone otoscope (Cellscope) to evaluate pediatric patient ears. Trainees' supervisors will evaluate patients remotely with the video on the cellphone otoscope. The study evaluates concordance of the exams.

    Device: Cellscope

Interventions

  • DeviceCellscope

    Cellphone otoscope (Cellscope) to evaluate pediatric patient ears.

06

What researchers measure

Primary outcomes

  1. Concordance of Trainee and Supervisor Utilizing the OMgrade Scale as Assessed by the Concordance-statistic

    Concordance of trainee and supervisor utilizing the OMgrade scale, between traditional otoscope and cellscope. Concordance is determined by the concordance-statistic (0-1) in a logistic regression model. The closer the number is to 1 the higher the concordance.

    Time frame: 6 months

Secondary outcomes

  1. Interrater Reliability as Assessed by a Kappa Statistic

    Kappa statistic (Fleiss' Kappa) of trainee and supervisor utilizing the OMgrade scale. The kappa statistic ranges from 0-1. The closer the number is to 1 the higher the agreement.

    Time frame: 6 months

  2. Number of Patients Who Receive Antibiotics

    Number of patients who receive antibiotics between traditional otoscope and cellscope.

    Time frame: 6 months

  3. Number of Participants Who Receive a Repeat Examination

    Number of participants who receive a repeat examination between traditional otoscope and cellscope.

    Time frame: 6 months

07

Results

Posted Sep 3, 2020

Participant flow

Participant flow — Overall Study
MilestoneTraditional OtoscopeCellscope
Started9899
Completed9899
Not completed00

Outcome measures

PrimaryConcordance of Trainee and Supervisor Utilizing the OMgrade Scale as Assessed by the Concordance-statistic

Concordance of trainee and supervisor utilizing the OMgrade scale, between traditional otoscope and cellscope. Concordance is determined by the concordance-statistic (0-1) in a logistic regression model. The closer the number is to 1 the higher the concordance.

Time frame:
6 months
Reported as:
Number · concordance-statistic
Concordance of Trainee and Supervisor Utilizing the OMgrade Scale as Assessed by the Concordance-statistic
concordance-statisticTraditional OtoscopeCellscope
Concordance of Trainee and Supervisor Utilizing the OMgrade Scale as Assessed by the Concordance-statistic0.64 (0.57 to 0.70)0.75 (0.69 to 0.81)
SecondaryInterrater Reliability as Assessed by a Kappa Statistic

Kappa statistic (Fleiss' Kappa) of trainee and supervisor utilizing the OMgrade scale. The kappa statistic ranges from 0-1. The closer the number is to 1 the higher the agreement.

Time frame:
6 months
Reported as:
Number · Fleiss' Kappa
Interrater Reliability as Assessed by a Kappa Statistic
Fleiss' KappaTraditional OtoscopeCellscope
Interrater Reliability as Assessed by a Kappa Statistic0.37 (0.24 to 0.51)0.67 (0.57 to 0.78)
SecondaryNumber of Patients Who Receive Antibiotics

Number of patients who receive antibiotics between traditional otoscope and cellscope.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Patients Who Receive Antibiotics
ParticipantsTraditional OtoscopeCellscope
Number of Patients Who Receive Antibiotics2111
SecondaryNumber of Participants Who Receive a Repeat Examination

Number of participants who receive a repeat examination between traditional otoscope and cellscope.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Participants Who Receive a Repeat Examination
ParticipantsTraditional OtoscopeCellscope
Number of Participants Who Receive a Repeat Examination9425

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Traditional Otoscope0/98 (0%)0/98 (0%)0/98 (0%)
Cellscope0/99 (0%)0/99 (0%)0/99 (0%)

Baseline characteristics

Age, Customized
Age, Customized(Participants)Traditional OtoscopeCellscopeTotal
21 years and younger9899197
Sex: Female, Male
Sex: Female, Male(Participants)Traditional OtoscopeCellscopeTotal
Female——0
Male——0
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Traditional OtoscopeCellscopeTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(Participants)Traditional OtoscopeCellscopeTotal
United States9899197
08

Study locations

1 site
  • Johns Hopkins Children's Center
    Baltimore, Maryland 21212, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 26, 2019
  • Informed consent form · Sep 6, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04296448
Lead sponsor
Johns Hopkins University
Responsible party
Sponsor
First posted
Mar 5, 2020
Start date
Sep 1, 2019
Primary completion
Mar 1, 2020
Completion
Mar 1, 2020
Results posted
Sep 3, 2020
Last update
Aug 26, 2021

Study contacts

Therese Canares, MD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion